We are live on
!
Find out more
FNBOO
First National Bank of Omaha Portfolio holdings
AUM
$3.55B
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.84%
1 Year Est. Return
+27.24%
3 Year Est. Return
+70.89%
5 Year Est. Return
+96.41%
10 Year Est. Return
+340.36%
AUM
$1.35B
AUM Growth
+$10.9M
(+0.81%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
18.9%
Holding
347
New
17
Increased
128
Reduced
121
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$4.85M |
| 2 |
Wells Fargo
WFC
|
+$4.46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.45M |
| 4 |
AGN
Allergan plc
AGN
|
+$4.41M |
| 5 |
Pfizer
PFE
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$5.9M |
| 2 |
CERN
Cerner Corp
CERN
|
+$5.11M |
| 3 |
Coca-Cola
KO
|
+$4.35M |
| 4 |
Jacobs Solutions
J
|
+$4.35M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Technology | 14.02% |
| 3 | Healthcare | 13.1% |
| 4 | Consumer Staples | 10.25% |
| 5 | Industrials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DPLO
226
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $561K | 0.04% |
16,025
+25
| +0.2% | +$786 |
|
227
Matador Resources
MTDR
$6.5B
| $559K | 0.04% |
28,250
+50
| +0.2% | +$1.08K |
|
228
Vanguard Total Bond Market
BND
$161B
| $554K | 0.04% |
6,577
-276
| -4% | -$22.9K |
|
|
SYNT
229
DELISTED
Syntel Inc
SYNT
| $549K | 0.04% |
12,125
+25
| +0.2% | +$1.13K |
|
|
OPB
230
DELISTED
Opus Bank Common Stock
OPB
| $537K | 0.04% |
15,900
+25
| +0.2% | +$885 |
|
231
General Mills
GIS
$20.4B
| $534K | 0.04% |
7,495
-6,581
| -47% | -$419K |
|
232
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.93B
| $532K | 0.04% |
10,600
| – | – |
|
|
IRBT
233
DELISTED
iRobot
IRBT
| $517K | 0.04% |
+14,750
| New | +$541K |
|
234
Lowe's Companies
LOW
$121B
| $517K | 0.04% |
6,536
+500
| +8% | +$38.7K |
|
|
GHDX
235
DELISTED
Genomic Health, Inc.
GHDX
| $485K | 0.04% |
18,725
+25
| +0.1% | +$664 |
|
|
PBPB
236
DELISTED
Potbelly
PBPB
| $481K | 0.04% |
+38,325
| New | +$511K |
|
237
Cemex
CX
$16.2B
| $477K | 0.04% |
80,422
-1
| -0% | -$6 |
|
238
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $474K | 0.04% |
5,899
-189
| -3% | -$15K |
|
239
Vanguard FTSE All-World ex-US ETF
VEU
$70.5B
| $473K | 0.04% |
11,050
-1,500
| -12% | -$65K |
|
240
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
| $462K | 0.03% |
7,500
-362
| -5% | -$21.9K |
|
241
Willis Towers Watson
WTW
$31.6B
| $455K | 0.03% |
3,659
-26,949
| -88% | -$3.33M |
|
|
PDCE
242
DELISTED
PDC Energy, Inc.
PDCE
| $452K | 0.03% |
7,850
+25
| +0.3% | +$1.48K |
|
|
CAMP
243
DELISTED
CalAmp Corp.
CAMP
| $449K | 0.03% |
1,318
+1
| +0.1% | +$351 |
|
244
Interparfums
IPAR
$3.78B
| $446K | 0.03% |
15,607
-2,093
| -12% | -$62.7K |
|
245
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
| $442K | 0.03% |
6,882
| – | – |
|
246
Dave & Buster's
PLAY
$361M
| $442K | 0.03% |
+9,450
| New | +$392K |
|
247
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
| $442K | 0.03% |
8,400
| – | – |
|
|
NATI
248
DELISTED
National Instruments Corp
NATI
| $431K | 0.03% |
15,725
-50
| -0.3% | -$1.39K |
|
249
Teleflex
TFX
$6.03B
| $421K | 0.03% |
2,375
-220
| -8% | -$35.9K |
|
250
Carpenter Technology
CRS
$26.3B
| $420K | 0.03% |
12,750
-450
| -3% | -$15K |
|
Similar funds
TYCC
WWA
VPC
BPS
BCP
TCM
SL
ACM
First National Bank of Omaha's Q2 2016 Portfolio in Review
As of Q2 2016, First National Bank of Omaha held 347 positions worth $1.35B, up 0.81% from $1.34B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
First National Bank of Omaha's Q2 2016 filing shows 17 new, 128 increased, 121 reduced and 31 closed positions. Its largest new stake was Boston Scientific: 223,979 shares worth $5.23M. The largest sale was Aflac, an estimated $5.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- First National Bank of Omaha's largest Q2 2016 buy was Boston Scientific: 223,979 shares worth $5.23M.
- First National Bank of Omaha added most to Wells Fargo in Q2 2016, an estimated $4.46M increase.
- First National Bank of Omaha's biggest Q2 2016 reduction was Aflac, cutting an estimated $5.9M.
- First National Bank of Omaha fully exited Jacobs Solutions in Q2 2016, selling an estimated $4.35M.
- First National Bank of Omaha's ten largest holdings make up 19% of its $1.35B portfolio in Q2 2016.
- First National Bank of Omaha opened 17 new positions and closed 31 in Q2 2016.
- First National Bank of Omaha's portfolio value rose 0.81% quarter-over-quarter to $1.35B.
Based on First National Bank of Omaha's 13F filing for Q2 2016, filed 19 Jul 2016.